Back to RENAISSANCE TECHNOLOGIES LLC RENAISSANCE TECHNOLOGIES LLC

CORTCORT
27 quarters

Position history for RENAISSANCE TECHNOLOGIES LLCRENAISSANCE TECHNOLOGIES LLC's holdings in CORCEPT THERAPEUTICS INC

RENAISSANCE TECHNOLOGIES LLC holds 5.3M shares of CORT (CORCEPT THERAPEUTICS INC), worth $457.5M as of 2026-Q2. The position was decreased (-7.4% shares). CORT represents 0.6% of RENAISSANCE TECHNOLOGIES LLC's portfolio.

Current Value

$457.5M

Current Shares

5.3M

Total Value Change

+$363.5M

Total Shares Change

-2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5.3M
-7.4%
$457.5M0.6%$86.95
0
2026-Q1
Decreased
5.7M
-1.3%
$229.1M0.4%$40.31
0
2025-Q4
Decreased
5.8M
-5.4%
$200.4M0.3%$34.80
0
2025-Q3
Decreased
6.1M
-2.8%
$506.1M0.7%$83.11
0
2025-Q2
Increased
6.3M
+2.0%
$460M0.6%$73.40
45
2025-Q1
Decreased
6.1M
-0.9%
$701.7M1.1%$114.22
0
2024-Q4
Decreased
6.2M
-4.8%
$312.3M0.5%$50.39
0
2024-Q3
Decreased
6.5M
-5.8%
$301.2M0.5%$46.28
0
2024-Q2
Decreased
6.9M
-2.9%
$224.6M0.4%$32.49
0
2024-Q1
Increased
7.1M
+5.8%
$179.3M0.3%$25.19
39
2023-Q4
Increased
6.7M
+1.7%
$218.5M0.3%$32.48
37
2023-Q3
Decreased
6.6M
-1.3%
$180.2M0.3%$27.25
0
2023-Q2
Decreased
6.7M
-1.3%
$149.1M0.2%$22.25
0
2023-Q1
Decreased
6.8M
-6.9%
$147M0.2%$21.66
0
2022-Q4
Increased
7.3M
+1.3%
$148M0.2%$20.31
37
2022-Q3
Decreased
7.2M
-8.1%
$184.5M0.3%$25.64
0
2022-Q2
Increased
7.8M
+0.8%
$186.3M0.2%$23.78
37
2022-Q1
Decreased
7.8M
-3.1%
$175M0.2%$22.52
0
2021-Q4
Decreased
8M
-2.7%
$158.9M0.2%$19.80
0
2021-Q3
Decreased
8.2M
-3.2%
$162.3M0.2%$19.68
0
2021-Q2
Decreased
8.5M
-2.9%
$187.5M0.2%$22.00
0
2021-Q1
Decreased
8.8M
-6.1%
$208.7M0.3%$23.79
0
2020-Q4
Decreased
9.3M
-2.8%
$244.4M0.3%$26.16
0
2020-Q3
Increased
9.6M
+7.7%
$167.2M0.2%$17.41
39
2020-Q2
Increased
8.9M
+7.4%
$150M0.1%$16.82
39
2020-Q1
Increased
8.3M
+6.9%
$98.7M0.1%$11.89
32
2019-Q4
New
7.8M
-
$94M0.1%$12.10
41

Other major holders of CORT: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used